Flomics Analysis
What is Flomics?
RNA-based diagnostics for early cancer detection
Employees
11-50
Founded
2018
Industry
Biotechnology
Interests
Artificial Intelligence, Health/Fitness/Wellbeing
Startup Tag
Yes
Product Features & Capabilities
- Multicancer blood test for early cancer detection
- Next-generation sequencing of cell-free RNA
- Machine learning models for data analysis
- Optimized protocols for RNA extraction
- Comprehensive bioinformatics support.
Use Cases
Detect cancer before symptoms appear; Screen at-risk individuals for multiple cancers; Analyze RNA patterns for disease diagnosis; Provide insights into tissue and cell states; Support early-stage cancer screening programs.
Other Considerations
Collaborates with clinical partners for research; Utilizes advanced machine learning techniques; Based in Barcelona, Spain.
4 Yfn Page Information
Main Information
- Information: Flomics Biotech is a company from Barcelona operating in the genomics and liquid biopsy space. They have developed a liquid biopsy test that provides clinically relevant information for the early detection and management of cancer and other complex diseases from a blood sample.
- Interests: Artificial Intelligence, Health/Fitness/Wellbeing
- Location: Hall 8.1 - 4YFN Stand 8.1C22.7A
- Tagged as startup: Yes
- LinkedIn: Connect on LinkedIn
- Twitter: Follow on X (formerly Twitter)
- Phone Number: Not available
- Email: Email
- Growth Stage: Series A
- Country: Spain
- Founding Year: 2018
- Company Name: Flomics Biotech
- Company Website: https://www.flomics.com
